Hemostasis 2008 Gordon Research Conference

描述(由申请人提供)： 本申请寻求对每年两次的戈登止血会议(GRC)的部分支持。GRC被广泛认为是关于凝血、血小板生物学和抗凝途径主题的首次小型会议，享有国内和国际声誉。该会议由止血先驱Earl W.Davie和Oscar Ratnoff于1973年首次组织，每年举行一次，直到20世纪90年代初的S，当时它通过了一年两次的会议时间表，旨在“与ISTH会议不同步”。最近两次非常成功的止血GRC分别于2004年和2006年在缅因州科尔比学院举行。下一次会议将于2006年6月29日至7月14日在新罕布夏州沃特维尔山谷的沃特维尔山谷会议中心举行，这是一个新的、舒适而诱人的地点，应该会为所有与会者提供一个极好的场所。总是超额认购，出席人数众多，并得到参与者的高度评价，2008年止血GRC将包括9个3小时的会议，将在分配的上午和晚上的时间段举行。海报展示将在五天中的四天在晚餐前举行。这些会议总是有很多人参加，为该领域的初级和高级科学家之间的互动提供了一个专门的、非正式的论坛。我们的GRC计划在周三晚上举行热门话题会议，这一会议很快成为我们的传统。主席和副主席在与2002年、2004年和2006年止血全球研究中心前主席进行了广泛、仔细的审议和协商后，精心挑选了37名发言者和讨论负责人。在这些中，除了少数人之外，我们已经收到了所有人的书面接受和生物素描。我们还作出了协调一致的努力，使妇女、种族和族裔少数群体、残疾人以及传统上在科学界代表性不足的群体中的其他个人作为发言者和讨论领导者得到适当的代表性。我们目前的受邀发言者和讨论领导人名单中已经包括11名妇女，我们希望增加妇女在我们发言者中的代表性，并在热点议题会议上包括代表人数不足的少数群体。最后，我们特别注意纳入了几个新的和创新的主题。这些是(1)抗血栓药物的基础和临床发展--将由来自学术界、大型制药公司和小型生物技术公司的非常有声望的科学家提供，他们在这一领域取得了杰出的成就，以及(2)动脉粥样硬化--这是一个由具有临床心脏病学、人类遗传学和生物工程专业知识的不同个人组成的及时的主题。这两个激动人心的会议，再加上我们更成熟的、传统的会议主题，应该会导致一次令人振奋的会议，涵盖血栓形成和止血领域的一系列及时学科。

DESCRIPTION (provided by applicant): This application seeks partial support for the bi-annual Gordon Conference (GRC) on Hemostasis. This GRC is widely considered to be the premiere small meeting on the topics of blood coagulation, platelet biology, and anticoagulant pathways, enjoying both national and international reputation. First organized by hemostasis pioneers Earl W. Davie and Oscar Ratnoff in 1973, the meeting was held annually until the early 1990's, when it adopted a bi-annual meeting schedule designed to be "out-of-sync the ISTH meeting. The last two highly successful Hemostasis GRCs were held at Colby College, Maine in 2004 and 2006. The next conference will be held on June 29th - July 4th 14, 2006 at Waterville Valley Conference Center, Waterville Valley, New Hampshire - a new, comfortable, and inviting location that should provide an excellent venue for all participants. Always oversubscribed, well-attended, and highly evaluated by its participants, the GRC on Hemostasis for 2008 will be comprised of nine 3 hour sessions that will be held in the allotted morning and evening time slots. Poster presentations will be held before dinner on four of the five days. These are always very well-attended, and provide a dedicated, informal forum for interaction between junior and more senior scientists in the field. A Hot Topics Session, quickly becoming a tradition at our GRC, is planned for Wednesday night. 37 Speakers and Discussion Leaders have been carefully chosen by the Chair and Vice- Chair after extensive, careful consideration and consultation with former Chairs of the 2002, 2004, and 2006 Hemostasis GRC. Of these, we already have written acceptances and Biosketches from all but a handful. We have also made a concerted effort to achieve appropriate representation of women, racial and ethnic minorities, persons with disabilities, and other individuals from groups that have traditionally been underrepresented in science as Speakers and Discussion Leaders. Our current list of invited speakers and discussion leaders already includes 11 women, and we expect to increase the representation of women among our speakers, as well as including underrepresented minorities, in the Hot Topics session. Finally, we have taken special care to include a couple of new and innovative topics. These are (1) Basic and Clinical Developments in Anti-Thrombotics - to be delivered by very well-regarded scientists from academics, big pharma, and small biotech with distinguished records of accomplishment in this area, and (2) Atherothrombosis - a timely topic to be covered by a diverse mixture of individuals with expertise in clinical cardiology, human genetics, and bioengineering. These two stimulating sessions, mixed in together with our more established, traditional session topics, should result in an invigorating meeting covering a range of timely disciplines in the fields of thrombosis and hemostasis.